Trials / Completed
CompletedNCT05318846
A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of HRS4800 tablets for postoperative analgesia after impacted teeth removal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS4800 tablets | Dosing frequency: single dose; Route of administration: oral |
| DRUG | Placebo tablets | Dosing frequency: single dose; Route of administration: oral |
Timeline
- Start date
- 2022-01-14
- Primary completion
- 2022-02-28
- Completion
- 2022-03-22
- First posted
- 2022-04-08
- Last updated
- 2022-04-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05318846. Inclusion in this directory is not an endorsement.